Citizens Financial Group Inc. (0HYP)
London Exchange · UK · prices in USD · close of 20 Oct 2026
Key indicators
| Last close | USD 64.25 |
|---|---|
| 52-week range | 46.96 – 75.48 |
| Return, 1 month / 3 months | −4.8% / −9.5% |
| Return, 1 year / 3 years | +31.5% / +181.4% |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 26.2% |
| Worst drawdown (1 year) | -18.0% |
| Average daily value traded | 0.18M USD |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Citizens Financial Group is a bank holding company based in Providence, Rhode Island, in the United States. Through its Citizens Bank subsidiary it serves retail customers and businesses, taking deposits and providing checking and savings accounts, mortgages, personal loans, credit cards, and commercial lending and treasury services. It also offers wealth management and other financial services to individuals and companies across its home market in the northeastern United States and beyond.
The shares are listed on the London Exchange in UK under the code 0HYP, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Citizens Financial Group Inc. (0HYP) trades on the London Exchange in UK. It last closed at USD 64.25 on 20 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,445 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 31.5% and over the last three months it fell 9.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -0.8% | ||
| From 52-week high | -14.0% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -9.5% | ||
| 6-month return | 0.2% | ||
| 12-month return, skipping the last month | 38.1% | ||
| Stability (higher is calmer) | 75 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.0% | ||
| Liquidity | 35 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.18M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 77 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.6% |
|---|---|
| 1 month | −4.8% |
| 3 months | −9.5% |
| 6 months | +0.2% |
| 1 year | +31.5% |
| 3 years | +181.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 67.77 / 64.77 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.58 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Jul 2026 | USD 0.4600 |
| 30 Apr 2026 | USD 0.4600 |
| 3 Feb 2026 | USD 0.4600 |
| 28 Oct 2025 | USD 0.4600 |
| 30 Jul 2025 | USD 0.4200 |
| 29 Apr 2025 | USD 0.4200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.